Lowmolecularweightheparinisageneraltermforaclassofrelativelylowmolecularweightheparinpreparedbydepolymerizationofcommonheparin.Itwasdevelopedinthe1970sbycombininganewclassofanticoagulantdrugs.Compared
Anticoagulantprincipleofheparinsodium:Heparinsodiumhasastronganticoagulanteffect,andisoftenusedasasystemicanticoagulantinanimalresuscitationexperiments.Theanticoagulanteffectofheparinsodiumismainlytoi
Effectofchondroitinsulfatesodiumtabletforadaptation:lipid-loweringdrugs.Itismainlyusedtotreathyperlipidemia.Itsclinicalapplicationsinclude:1.Chondroitinsulfate,asahealthfoodordrug,hasbeenusedforthelon
Indications:Patientswithunstableanginaandnon-ST-elevationmyocardialinfarctionwhoundergoprophylactictreatmentforischemiccomplications,preventionofdeepveinthrombosiscandevelop,andpreventionofclottingdur